Concepedia

Marco Borgogno

MB

6

Publications

171

Citations

6

H-Index

2017

Active since

Affiliations

Italian Institute of Technology(Current)

University of Genoa

University of Bologna

Dulbecco Telethon Institute

Forschungszentrum Jülich

Marco Borgogno is an author at Italian Institute of Technology specializing in drug development, drug discovery, and medicine.

ORCID

Top concepts

Publications per year

2017–2023

6

Publications

6

Discovery of a Small Molecule Drug Candidate for Selective NKCC1 Inhibition in Brain Disorders

Annalisa Savardi, Marco Borgogno, Roberto Narducci et al. · Chem · 2020 · 59 citations · Full text

Pharmacophore Hybridization To Discover Novel Topoisomerase II Poisons with Promising Antiproliferative Activity

José Antonio Ortega, Laura Riccardi, Elirosa Minniti et al. · Journal of Medicinal Chemistry · 2017 · 36 citations · Full text

, , +11

Novel, Potent, and Druglike Tetrahydroquinazoline Inhibitor That Is Highly Selective for Human Topoisomerase II α over β

José Antonio Ortega, José M. Arencibia, Elirosa Minniti et al. · Journal of Medicinal Chemistry · 2020 · 26 citations · Full text

Design, Synthesis, <i>In Vitro</i> and <i>In Vivo</i> Characterization of Selective NKCC1 Inhibitors for the Treatment of Core Symptoms in Down Syndrome

Marco Borgogno, Annalisa Savardi, Jacopo Manigrasso et al. · Journal of Medicinal Chemistry · 2021 · 20 citations · Full text

Pharmacophore Identification and Scaffold Exploration to Discover Novel, Potent, and Chemically Stable Inhibitors of Acid Ceramidase in Melanoma Cells

José Antonio Ortega, José M. Arencibia, Giuseppina La Sala et al. · Journal of Medicinal Chemistry · 2017 · 19 citations · Full text

, , +14

Rows per page

1–5 of 6